OmniAb
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
8 of 43
Similar slides by OmniAb
See diffirences between slides (animation)
Investor Presentation
August 2023
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
Investor Presentation
May 2023
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
Investor Conference
November 2022
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
Other recent decks by OmniAb
See all presentations (10 decks)
Results
November 2024
Results
March 2024
Results
August 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io